dc.contributor.author |
Bhadraiah, U K |
|
dc.contributor.author |
Ningaiah, S |
|
dc.contributor.author |
Basavanna, V |
|
dc.contributor.author |
Shanthakumar, D C |
|
dc.contributor.author |
Chandramouli, M |
|
dc.contributor.author |
Chandra |
|
dc.contributor.author |
Puttaswamy, T M |
|
dc.contributor.author |
Doddamani, S |
|
dc.date.accessioned |
2023-01-31T06:11:17Z |
|
dc.date.available |
2023-01-31T06:11:17Z |
|
dc.date.issued |
2021 |
|
dc.identifier.citation |
Biointerface Research in Applied Chemistry;11(2):9443-9455 |
en_US |
dc.identifier.uri |
https://doi.org/10.33263/briac112.94439455 |
|
dc.identifier.uri |
http://localhost:8080/xmlui/handle/123456789/4233 |
|
dc.description.abstract |
In the current study, bicyclic 1-(7-methyl-3,5-diphenyl-5H-thiazolo(3,2-α)pyrimidine-6-
yl)ethanone (4a-l) derivatives have been designed and conveniently synthesized by one-pot threecomponent method via cyclocondensation of substituted 4-phenylthiazole-2-amine (1a-c),
acetylacetone (2) and various aromatic aldehydes (3a-d) in the presence of p-toluene sulfonic acid
(PTSA) under acetonitrile solvent medium. The synthesized compounds (4a-l) have been characterized
by spectral analysis and subjected to docking study against protein DNA gyrase (PDB Code: 1KZN),
and also, the compounds were screened for their in vitro antimicrobial activities. The bioassay of the
synthesized compounds envisioned that the compound 4k emerged as a broad-spectrum antibacterial
agent, and 4l emerged as a good antifungal agent compared to standard drug. |
en_US |
dc.language.iso |
en |
en_US |
dc.subject |
thiazolo[3,2-α]pyrimidine |
en_US |
dc.subject |
one-pot three-component reaction |
en_US |
dc.subject |
docking studies |
en_US |
dc.subject |
antimicrobial activity |
en_US |
dc.title |
Thiazolo-Pyrimidine Analogues: Synthesis, Characterization and Docking Studies Guided Antimicrobial Activities |
en_US |
dc.type |
Article |
en_US |